Clinical Trials

NCT05470218 | ACTIVE_NOT_RECRUITING | NA
10 participants

Leucine, mTOR and Athero

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2022-07-12
Completion:
2023-08-14
Conditions
  • Atherosclerosis
Interventions
  • OTHER
No Results Yet
NCT05457283 | RECRUITING | PHASE3
100 participants

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2022-11-08
Completion:
2029-01-28
Conditions
  • Chronic Kidney Disease
  • Proteinuria
  • Children
Interventions
  • DRUG
No Results Yet
NCT05453396 | RECRUITING | PHASE2
20 participants

Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2023-08-07
Completion:
2027-12-15
Conditions
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Mantle Cell Lymphoma
Interventions
  • BIOLOGICAL
  • PROCEDURE
No Results Yet
NCT05379153 | RECRUITING | PHASE3
250 participants

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2026-04-21
Completion:
2026-09-30
Conditions
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage IA Breast Cancer AJCC v8
  • Anatomic Stage IB Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Vaginal Atrophy
Interventions
  • DEVICE
  • OTHER
No Results Yet
NCT05357378 | RECRUITING | NA
288 participants

Safety and Effectiveness of the HIT Reverse HRS

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2022-07-15
Completion:
2026-07-15
Conditions
  • Degenerative Joint Disease
  • Osteoarthritis, Hip
  • Avascular Necrosis of Hip
  • Traumatic Arthropathy-Hip
Interventions
  • DEVICE
No Results Yet
NCT05334069 | RECRUITING
2000 participants

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-11
Start Date:
2022-08-18
Completion:
2027-01-31
Conditions
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Ann Arbor Stage I Lymphoma
  • Ann Arbor Stage II Lymphoma
  • Ann Arbor Stage III Lymphoma
  • Ann Arbor Stage IV Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Gastroesophageal Junction Adenocarcinoma
  • Head and Neck Carcinoma
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Invasive Breast Carcinoma
  • Kidney Carcinoma
  • Malignant Hepatobiliary Neoplasm
  • Malignant Solid Neoplasm
  • Melanoma
  • Muscle-Invasive Bladder Carcinoma
  • RISS Stage I Plasma Cell Myeloma
  • RISS Stage II Plasma Cell Myeloma
  • RISS Stage III Plasma Cell Myeloma
  • Sarcoma
  • Stage I Bladder Cancer AJCC v6 and v7
  • Stage I Breast Cancer AJCC v7
  • Stage I Colorectal Cancer AJCC v6 and v7
  • Stage I Esophageal Cancer AJCC V7
  • Stage I Gastric Cancer AJCC V7
  • Stage I Lung Cancer AJCC v7
  • Stage I Ovarian Cancer AJCC v6 and v7
  • Stage I Pancreatic Cancer AJCC v6 and v7
  • Stage I Prostate Cancer AJCC v7
  • Stage I Uterine Corpus Cancer AJCC v7
  • Stage II Bladder Cancer AJCC v6 and v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage II Colorectal Cancer AJCC v7
  • Stage II Esophageal Cancer AJCC v7
  • Stage II Gastric Cancer AJCC v7
  • Stage II Lung Cancer AJCC v7
  • Stage II Ovarian Cancer AJCC v6 and v7
  • Stage II Pancreatic Cancer AJCC v6 and v7
  • Stage II Prostate Cancer AJCC v7
  • Stage II Uterine Corpus Cancer AJCC v7
  • Stage III Bladder Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Stage III Colorectal Cancer AJCC v7
  • Stage III Esophageal Cancer AJCC v7
  • Stage III Gastric Cancer AJCC v7
  • Stage III Lung Cancer AJCC v7
  • Stage III Ovarian Cancer AJCC v6 and v7
  • Stage III Pancreatic Cancer AJCC v6 and v7
  • Stage III Prostate Cancer AJCC v7
  • Stage III Uterine Corpus Cancer AJCC v7
  • Stage IV Bladder Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
  • Stage IV Colorectal Cancer AJCC v7
  • Stage IV Esophageal Cancer AJCC v7
  • Stage IV Gastric Cancer AJCC v7
  • Stage IV Lung Cancer AJCC v7
  • Stage IV Ovarian Cancer AJCC v6 and v7
  • Stage IV Pancreatic Cancer AJCC v6 and v7
  • Stage IV Prostate Cancer AJCC v7
  • Stage IV Uterine Corpus Cancer AJCC v7
  • Thyroid Gland Carcinoma
Interventions
  • OTHER
  • PROCEDURE
No Results Yet
NCT05319873 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
18 participants

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2022-04-07
Completion:
2027-04-01
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Invasive Breast Carcinoma
  • Locally Advanced HER2-Positive Breast Carcinoma
  • Metastatic HER2-Positive Breast Carcinoma
  • Prognostic Stage IB Breast Cancer AJCC v8
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT05300997 | RECRUITING
650 participants

Translational Immunodiagnostics in Stroke (TrImS)

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-11
Start Date:
2022-05-01
Completion:
2027-08-31
Conditions
  • Acute Ischemic Stroke
  • Haemorrhagic Stroke
  • Transient Ischemic Attacks
  • Cardioembolic Stroke
  • Large-Artery Atherosclerosis (Embolus/Thrombosis)
  • Small Vessel Disease
  • Stroke of Other Determined Etiology
  • Stroke of Undetermined Etiology
  • Atrial Fibrillation
  • Stroke of Anterior Cerebral Artery
  • Stroke of Middle Cerebral Artery
  • Stroke of Basilar Artery
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT05264779 | RECRUITING | NA
300 participants

The Periviable GOALS Decision Support Tool

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-11
Start Date:
2022-06-06
Completion:
2026-08-31
Conditions
  • Pregnancy Preterm
  • Premature Birth
  • Pregnancy Complications
  • Obstetric Labor, Premature
  • Obstetric Labor Complications
Interventions
  • OTHER
No Results Yet
NCT05255042 | COMPLETED
36 participants

Tissue Models for Liver Disease

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-11
Start Date:
2021-09-08
Completion:
2025-06-25
Conditions
  • Liver Diseases
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page